Related Experiment Video
Updated: Jan 16, 2026
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
NOTCH gene pattern predicts prognosis, immune infiltration, and drug response in Head and Neck squamous cell
Shanliang Ye1, Lin Huang2, Liyu Ma3
1Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China; Department of Gastroenterology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
Background:
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive cancer with poor prognosis. Although NOTCH signaling is frequently inactivated in HNSCC, the prognostic significance of NOTCH-related genes and their link to the tumor microenvironment remain unclear.
Methods:
NOTCH-related genes were identified in HNSCC patients through univariate Cox regression and differential expression analyses. A prognostic risk model (NOTCH score) was constructed using LASSO regression. The association between the NOTCH score and clinical outcomes, immune infiltration, therapy response sensitivity was comprehensively evaluated. Single-cell RNA sequencing and immunohistochemistry were used to assess the cellular and tissue distribution of risk genes.
Results:
Seven candidate genes (COL28A1, EFEMP1, FGF9, FMOD, ITGA5, ROBO1, and THBS1) were selected to construct the NOTCH-based prognostic model. Patients were stratified into high- and low-risk groups based on the median NOTCH score. High-risk patients exhibited significantly worse survival compared to the low-risk group. ROC analysis demonstrated robust prognostic performance, with AUC values exceeding 0.7 for 3-year survival in both training and validation cohorts. High NOTCH scores were associated with an immunosuppressive tumor microenvironment and poor response to immunotherapy. Drug sensitivity analysis revealed that high-risk patients were more sensitive to agents such as CMK, Parthenolide, and Thapsigargin. At both the single-cell and protein levels, the seven genes were predominantly expressed in fibroblasts and endothelial cells, suggesting their potential involvement in tumor stromal remodeling and microenvironment regulation.
Conclusion:
We developed and validated a NOTCH-based prognostic model with strong predictive power in HNSCC. The NOTCH score may help assess immune status, predict treatment response, and guide personalized therapy.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Related Concept Videos
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...